Global Agricultural Exports · India
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly due to a deficiency or absence of essential clotting factors, resulting in spontaneous hemorrhages into joints and long-term musculoskeletal disabilities.
While India is home to nearly one-fourth of the world's hemophilic population, over 80% of individuals remain undiagnosed due to a severe shortage of specialized coagulation assays at district levels. Unrecognized bleeding into knees, ankles, and elbows is frequently misidentified as orthopedic trauma, leading to preventable joint fusion, physical deformity, or fatal internal hemorrhages.
Because hemophilia follows an X-linked recessive pattern, it manifests overwhelmingly in males, while females function predominantly as carriers who transmit the gene.
A structured community-to-hospital model addressing every critical gap from missed identification to specialized clinical care, medicine supply, and patient dignity.
Running active detection drives across tier-2/tier-3 talukas, deploying screening coagulation tests at PHCs, and bridging India’s 80% undiagnosed patient gap through state-wide verified registries.
Upgrading district hospitals with dedicated infusion recliner beds, 24/7 cold-chain units, emergency resuscitation kits, and specialized post-bleed physiotherapy to stop permanent joint arthropathy.
Collaborating with state medical procurement corporations and funding emergency buffer stocks of Factor VIII & IX concentrates to eliminate catastrophic stock-outs during acute bleeding episodes.
Conducting local-language education for school teachers, rural families, and grassroots ASHA/ANM health workers. Training clinicians to avoid fatal intramuscular injections or contraindicated blood thinners.
Providing travel conveyance allowances for indigent families visiting treatment hubs, educational scholarships for affected children, disability pension registrations, and livelihood assistance.
Providing pedigree mapping, subsidized mutation testing, pre-marital carrier identification, and non-judgmental psycho-social counseling to at-risk families to prevent intergenerational trauma.
Our hemophilia healthcare and social welfare framework systematically aligns with the United Nations 2030 targets.